{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:36:28Z","timestamp":1740108988601,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>The accurate selection of patients who are most likely to benefit from neoadjuvant chemotherapy is an important challenge in oncology. Serum AGR has been found to be associated with oncological outcomes in various malignancies. We assessed the association of pre-therapy serum albumin-to-globulin ratio (AGR) with pathologic response and oncological outcomes in patients treated with neoadjuvant platin-based chemotherapy followed by radical nephroureterectomy (RNU) for clinically non-metastatic UTUC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively included all clinically non-metastatic patients from a multicentric database who had neoadjuvant platin-based chemotherapy and RNU for UTUC. After assessing the pretreatment AGR cut\u2010off value, we found 1.42 to have the maximum Youden index value. The overall population was therefore divided into two AGR groups using this cut\u2010off (low,\u2009&lt;\u20091.42 vs high,\u2009\u2265\u20091.42)<jats:italic>.<\/jats:italic>A logistic regression was performed to measure the association with pathologic response after NAC. Univariable and multivariable Cox regression analyses tested the association of AGR with OS and RFS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 172 patients, 58 (34%) patients had an AGR\u2009&lt;\u20091.42. Median follow-up was 26 (IQR 11\u201356) months. In logistic regression, low AGR was not associated with pathologic response. On univariable analyses, pre-therapy serum AGR was neither associated with OS HR 1.15 (95% CI 0.77\u20131.74;<jats:italic>p<\/jats:italic>\u2009=\u20090.47) nor RFS HR 1.48 (95% CI 0.98\u20131.22;<jats:italic>p<\/jats:italic>\u2009=\u20090.06). These results remained true regardless of the response to NAC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Pre-therapy low serum AGR before NAC followed by RNU for clinically high-risk UTUC was not associated with pathological response or long-term oncological outcomes. Biomarkers that can complement clinical factors in UTUC are needed as clinical staging and risk stratification are still suboptimal leading to both over and under treatment despite the availability of effective therapies.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s00345-020-03479-3","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T18:02:45Z","timestamp":1602871365000},"page":"2567-2577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7768-8558","authenticated-orcid":false,"given":"Benjamin","family":"Pradere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor M.","family":"Schuettfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beat","family":"Foerster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Quhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Abufaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Deuker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Muilwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kees","family":"Hendricksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Karakiewic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh","family":"F.Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the UTUC collaboration","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"issue":"1","key":"3479_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3479_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupr\u00eat","year":"2018","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat E, Zigeuner R, Sylvester RJ, Burger M et al (2018) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. Eur Urol 73(1):111\u2013122","journal-title":"Eur Urol"},{"issue":"8","key":"3479_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nrurol.2011.96","volume":"8","author":"TF Chromecki","year":"2011","unstructured":"Chromecki TF, Bensalah K, Remzi M, Verhoest G, Cha EK, Scherr DS et al (2011) Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol 8(8):440\u2013447","journal-title":"Nat Rev Urol"},{"issue":"2","key":"3479_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.eururo.2011.09.017","volume":"61","author":"TF Chromecki","year":"2012","unstructured":"Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS et al (2012) The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 61(2):245\u2013253","journal-title":"Eur Urol"},{"issue":"1","key":"3479_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.eururo.2012.04.052","volume":"65","author":"E Xylinas","year":"2014","unstructured":"Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H et al (2014) Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 65(1):210\u2013217","journal-title":"Eur Urol"},{"key":"3479_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10147-020-01650-9","volume":"25","author":"F Quhal","year":"2020","unstructured":"Quhal F, Mori K, Sari Motlagh R, Laukhtina E, Pradere B, Roupr\u00eat M et al (2020) Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis. Int J Clin Oncol 25:1037\u20131054. https:\/\/doi.org\/10.1007\/s10147-020-01650-9","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"3479_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1464-410X.2012.11649.x","volume":"112","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E et al (2013) Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int 112(4):453\u2013461","journal-title":"BJU Int"},{"issue":"17","key":"3479_CR8","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1158\/1078-0432.CCR-10-0457","volume":"16","author":"RS Svatek","year":"2010","unstructured":"Svatek RS, Shariat SF, Lasky RE, Skinner EC, Novara G, Lerner SP et al (2010) The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder. Clin Cancer Res Off J Am Assoc Cancer Res 16(17):4461\u20134467","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"3479_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30415-3","author":"A Birtle","year":"2020","unstructured":"Birtle A, Johnson M, Chester J, Jones R, Dolling D, Bryan RT et al (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(20)30415-3","journal-title":"Lancet"},{"key":"3479_CR10","doi-asserted-by":"crossref","unstructured":"Roupr\u00eat M, Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM et al (2020) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. Eur Urol","DOI":"10.1016\/j.eururo.2020.05.042"},{"issue":"3","key":"3479_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1464-410X.2008.08003.x","volume":"103","author":"M Remzi","year":"2009","unstructured":"Remzi M, Haitel A, Margulis V, Karakiewicz P, Karakiewizc P, Montorsi F et al (2009) Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 103(3):307\u2013311","journal-title":"BJU Int"},{"key":"3479_CR12","doi-asserted-by":"publisher","unstructured":"Foerster B, Abufaraj M, Petros F, Azizi M, Gupta M, Schweitzer D et al (2020) Efficacy of preoperative chemotherapy in high risk upper tract urothelial carcinoma. J Urol. https:\/\/doi.org\/10.1097\/JU.0000000000000737","DOI":"10.1097\/JU.0000000000000737"},{"issue":"1","key":"3479_CR13","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1038\/s41467-019-10873-y","volume":"10","author":"BD Robinson","year":"2019","unstructured":"Robinson BD, Vlachostergios PJ, Bhinder B, Liu W, Li K, Moss TJ et al (2019) Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling. Nat Commun 10(1):2977","journal-title":"Nat Commun"},{"issue":"4","key":"3479_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/ijms20040793","volume":"20","author":"J Tse","year":"2019","unstructured":"Tse J, Ghandour R, Singla N, Lotan Y (2019) Molecular predictors of complete response following neoadjuvant chemotherapy in urothelial carcinoma of the bladder and upper tracts. Int J Mol Sci. 20(4):793","journal-title":"Int J Mol Sci."},{"issue":"12","key":"3479_CR15","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1600-0463.2010.02648.x","volume":"118","author":"KH Kim","year":"2010","unstructured":"Kim KH, Do I-G, Kim HS, Chang MH, Kim HS, Jun HJ et al (2010) Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapy. APMIS Acta Pathol Microbiol Immunol Scand 118(12):941\u2013948","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"issue":"4","key":"3479_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.urolonc.2010.02.011","volume":"28","author":"SF Shariat","year":"2010","unstructured":"Shariat SF, Lotan Y, Vickers A, Karakiewicz PI, Schmitz-Dr\u00e4ger BJ, Goebell PJ et al (2010) Statistical consideration for clinical biomarker research in bladder cancer. Urol Oncol 28(4):389\u2013400","journal-title":"Urol Oncol"},{"issue":"6","key":"3479_CR17","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.eururo.2007.09.036","volume":"52","author":"K Bensalah","year":"2007","unstructured":"Bensalah K, Montorsi F, Shariat SF (2007) Challenges of cancer biomarker profiling. Eur Urol 52(6):1601\u20131609","journal-title":"Eur Urol"},{"issue":"13","key":"3479_CR18","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.7150\/jca.24889","volume":"9","author":"J Chi","year":"2018","unstructured":"Chi J, Xie Q, Jia J, Liu X, Sun J, Chen J et al (2018) Prognostic value of albumin\/globulin ratio in survival and lymph node metastasis in patients with cancer: a systematic review and meta-analysis. J Cancer 9(13):2341\u20132348","journal-title":"J Cancer"},{"issue":"11","key":"3479_CR19","first-page":"484.e1","volume":"34","author":"J Liu","year":"2016","unstructured":"Liu J, Dai Y, Zhou F, Long Z, Li Y, Liu B et al (2016) The prognostic role of preoperative serum albumin\/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy. Urol Oncol Semin Orig Investig 34(11):484.e1-484.e8","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"3","key":"3479_CR20","doi-asserted-by":"publisher","first-page":"e655","DOI":"10.1016\/j.clgc.2017.12.013","volume":"16","author":"N Niwa","year":"2018","unstructured":"Niwa N, Matsumoto K, Ide H, Nagata H, Oya M (2018) Prognostic value of pretreatment albumin-to-globulin ratio in patients with non-muscle-invasive bladder cancer. Clin Genitourin Cancer 16(3):e655\u2013e661","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"3479_CR21","doi-asserted-by":"publisher","first-page":"e1059","DOI":"10.1016\/j.clgc.2018.06.003","volume":"16","author":"H Xu","year":"2018","unstructured":"Xu H, Tan P, Ai J, Huang Y, Lin T, Yang L et al (2018) Prognostic impact of preoperative albumin-globulin ratio on oncologic outcomes in upper tract urothelial carcinoma treated with radical nephroureterectomy. Clin Genitourin Cancer 16(5):e1059\u2013e1068","journal-title":"Clin Genitourin Cancer"},{"issue":"12","key":"3479_CR22","doi-asserted-by":"publisher","first-page":"e0144961","DOI":"10.1371\/journal.pone.0144961","volume":"10","author":"B Zhang","year":"2015","unstructured":"Zhang B, Yu W, Zhou L-Q, He Z-S, Shen C, He Q et al (2015) Prognostic significance of preoperative albumin-globulin ratio in patients with upper tract urothelial carcinoma Gao X, editor. PLoS ONE 10(12):e0144961","journal-title":"PLoS ONE"},{"key":"3479_CR23","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.2147\/CMAR.S178271","volume":"10","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang L, Lin S, Wang R (2018) Preoperative albumin-to-globulin ratio as a significant prognostic indicator in urologic cancers: a meta-analysis. Cancer Manag Res 10:4695\u20134708","journal-title":"Cancer Manag Res"},{"issue":"6","key":"3479_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448\u2013454","journal-title":"N Engl J Med"},{"issue":"19","key":"3479_CR25","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.7150\/jca.21141","volume":"8","author":"J He","year":"2017","unstructured":"He J, Pan H, Liang W, Xiao D, Chen X, Guo M et al (2017) Prognostic effect of albumin-to-globulin ratio in patients with solid tumors: a systematic review and meta-analysis. J Cancer 8(19):4002\u20134010","journal-title":"J Cancer"},{"key":"3479_CR26","first-page":"2856","volume":"5","author":"Q Li","year":"2015","unstructured":"Li Q, Meng X, Liang L, Xu Y, Cai G, Cai S (2015) High preoperative serum globulin in rectal cancer treated with neoadjunctive chemoradiation therapy is a risk factor for poor outcome. Am J Cancer Res 5:2856","journal-title":"Am J Cancer Res"},{"issue":"4","key":"3479_CR27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.eururo.2010.07.003","volume":"58","author":"RL Favaretto","year":"2010","unstructured":"Favaretto RL, Shariat SF, Chade DC, Godoy G, Adamy A, Kaag M et al (2010) The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 58(4):574\u2013580","journal-title":"Eur Urol"},{"issue":"18","key":"3479_CR28","first-page":"3291","volume":"45","author":"G Lughezzani","year":"2009","unstructured":"Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Alasker A et al (2009) Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. Eur J Cancer Oxf Engl 1990 45(18):3291\u20133297","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"4","key":"3479_CR29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.eururo.2011.07.009","volume":"60","author":"M Roscigno","year":"2011","unstructured":"Roscigno M, Brausi M, Heidenreich A, Lotan Y, Margulis V, Shariat SF et al (2011) Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol 60(4):776\u2013783","journal-title":"Eur Urol"},{"volume-title":"World Health Organization Classification of Tumours. Pathology and genetics of tumours of the urinary system and male genital organs","year":"2004","key":"3479_CR30","unstructured":"Eble J, Sauter G, Epstein J, Sesterhenn IA (eds) (2004) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon"},{"issue":"5","key":"3479_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000490149","volume":"95","author":"Y Toiyama","year":"2018","unstructured":"Toiyama Y, Oki S, Okugawa Y, Ide S, Yasuda H, Fujikawa H et al (2018) Clinical impact of preoperative albumin-globulin ratio in patients with rectal cancer treated with preoperative chemoradiotherapy. Oncology 95(5):270\u2013280","journal-title":"Oncology"},{"key":"3479_CR32","doi-asserted-by":"publisher","first-page":"doz082","DOI":"10.1093\/dote\/doz082","volume":"33","author":"SJM van Hootegem","year":"2019","unstructured":"van Hootegem SJM, Smithers BM, Gotley DC, Brosda S, Thomson IG, Thomas JM et al (2019) Baseline neutrophil-lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy. Dis Esophagus 33:doz082","journal-title":"Dis Esophagus"},{"issue":"8","key":"3479_CR33","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3760\/cma.j.issn.0366-6999.20122672","volume":"126","author":"D Wang","year":"2013","unstructured":"Wang D, Wu M, Feng F, Huang H, Yang J, Shen K et al (2013) Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy. Chin Med J (Engl) 126(8):1464\u20131468","journal-title":"Chin Med J (Engl)"},{"key":"3479_CR34","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2147\/OTT.S148496","volume":"11","author":"Y Qian","year":"2018","unstructured":"Qian Y, Tao J, Li X, Chen H, Lu Q, Yang J et al (2018) Peripheral inflammation\/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy. OncoTargets Ther 11:1423\u20131432","journal-title":"OncoTargets Ther"},{"key":"3479_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.breast.2018.12.014","volume":"44","author":"V Graziano","year":"2019","unstructured":"Graziano V, Grassadonia A, Iezzi L, Vici P, Pizzuti L, Barba M et al (2019) Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Breast Edinb Scotl 44:33\u201338","journal-title":"Breast Edinb Scotl"},{"issue":"4","key":"3479_CR36","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1016\/j.clgc.2015.02.001","volume":"13","author":"J-A Seah","year":"2015","unstructured":"Seah J-A, Leibowitz-Amit R, Atenafu EG, Alimohamed N, Knox JJ, Joshua AM et al (2015) Neutrophil-lymphocyte ratio and pathological response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer. Clin Genitourin Cancer 13(4):e229\u2013e233","journal-title":"Clin Genitourin Cancer"},{"key":"3479_CR37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s10120-019-01027-6","volume":"23","author":"Z Li","year":"2020","unstructured":"Li Z, Li S, Ying X, Zhang L, Shan F, Jia Y et al (2020) The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy. Gastric Cancer 23:540\u2013549","journal-title":"Gastric Cancer"},{"key":"3479_CR38","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.2147\/OTT.S135641","volume":"10","author":"H Jin","year":"2017","unstructured":"Jin H, Sun J, Zhu K, Liu X, Zhang Q, Shen Q et al (2017) The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up. OncoTargets Ther 10:2655\u20132664","journal-title":"OncoTargets Ther"},{"issue":"5","key":"3479_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1748-717X-5-47","volume":"3","author":"J Kitayama","year":"2010","unstructured":"Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H (2010) Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol Lond Engl 3(5):47","journal-title":"Radiat Oncol Lond Engl"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03479-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-020-03479-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03479-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:49:08Z","timestamp":1723769348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-020-03479-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3479"],"URL":"https:\/\/doi.org\/10.1007\/s00345-020-03479-3","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"type":"print","value":"0724-4983"},{"type":"electronic","value":"1433-8726"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors state that they have no conflict of interest that might bias this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study has been approved by the appropriate ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Yes.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}